Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer.
Son J, Lin HY, Fu S, Biter AB, Dumbrava EE, Karp DD, Naing A, Pant S, Piha-Paul SA, Rodon J, Subbiah V, Tsimberidou AM, Yap TA, Frumovitz MM, Jazaeri AA, Ramirez PT, Westin SN, Yuan Y, Meric-Bernstam F, Hong DS.
Son J, et al. Among authors: jazaeri aa.
J Immunother Precis Oncol. 2023 Jan 6;6(1):10-18. doi: 10.36401/JIPO-22-23. eCollection 2023 Feb.
J Immunother Precis Oncol. 2023.
PMID: 36751659
Free PMC article.